查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2125252

神經外科器材：市場洞察、競爭格局及市場預測 - 2034 年

Neurosurgery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

概述：

  • 2025年全球神經外科器械市場價值145億美元，預計2034年將達到453.2億美元。
  • 在 2026 年至 2034 年的預測期內，市場預計將以 13.5% 的複合年成長率成長，這得益於腦腫瘤和神經系統疾病患病率的上升、向微創和圖像引導神經外科手術的轉變、手術機器人和立體定向技術的進步，以及整個神經外科設備組合的持續技術創新。
  • 按產品類型分類，預計到 2025 年，神經外科導航系統細分市場將佔 22% 的佔有率，從而推動神經外科設備市場的發展。
  • 按應用領域分類，預計到 2025 年，腦腫瘤手術領域將佔市場佔有率的 30%，從而推動神經外科器械市場的發展。
  • 按最終用戶分類，預計到 2025 年，醫院領域將佔市場佔有率的 78%，從而推動神經外科器械市場的發展。
  • 截至 2025 年，北美在神經外科器械市場中佔最大佔有率，為 38%，但預計到 2034 年，亞太地區將實現最快成長。

神經外科器械是指用於診斷、定位、治療和監測腦部、脊髓和周邊神經系統疾病的儀器、植入和大型設備。它們包括用於規劃和引導神經外科手術的工具、用於實施手術的器械以及用於術後修復和管理的植入和材料。該市場按供應產品、手術應用和臨床環境進行細分，本報告採用的產品構成遵循主要製造商對其神經外科產品系列組合的分類方式。平台技術包括用於即時識別解剖結構的神經外科導航系統、術中成像系統以及用於沿預定軌跡定位器械的立體定向和機器人引導系統。電動手術器械，例如主要用於切割和塑形骨骼的高速手術鑽，以及用於內視鏡和顱底入路的神經科學用內視鏡，可用於手術部位的定位和切除。超音波吸引系統用於切除腫瘤組織，動脈瘤夾和神經血管夾用於閉塞血管病變，雷射間質熱療系統在影像引導下消融病變。腦脊髓液管理裝置，包括分流器、可程式設計閥門和外引流裝置，用於治療水腦症和控制顱內壓。神經監測和顱內壓測量裝置用於追蹤受損腦組織或手術過程中腦組織的狀況。硬腦膜修復和密封裝置用於修復硬腦膜，顱骨穩定和固定裝置用於固定頭部和重組顱骨。目前市場的特徵是向微創和影像導引手術轉變，顱腦機器人技術快速發展，以及人工智慧（AI）在手術規劃和導航中的應用。

神經外科器械市場的主要市場促進因素

  • 腦腫瘤和神經系統疾病的發生率在全球範圍內不斷上升。根據美國國家腦腫瘤協會統計，美國約有70萬人患有腦腫瘤，推動了對腫瘤切除術及相關設備的需求。
  • 此外，隨著人口老化，腦腫瘤、腦血管疾病、正常水腦症以及需要神經外科手術干預的退化性疾病的發生率正在增加。
  • 微創、影像引導的神經外科手術正日益成為一種趨勢。與開放手術相比，導航、內視鏡和管狀通路等技術能夠縮短住院時間並降低併發症風險。
  • 外科機器人和立體定位引導技術的快速發展，例如顱內機器人平台可以精確定位切片檢查、電極放置和雷射消熔的器械。
  • 在整個產品組合中不斷進行技術創新，包括術中成像、雷射間質熱療、超音波抽吸，以及將人工智慧 (AI) 和纖維束成像技術整合到手術計劃中。
  • 由於診斷技術的進步和醫療保健服務的擴大，腫瘤切除、水腦症治療、癲癇和功能性手術以及神經創傷等神經外科手術的數量正在增加。
  • 新興市場醫療保健投資的增加和神經外科手術能力的擴大，使得以前缺乏足夠醫療服務的患者能夠獲得治療。

推動神經外科器械市場成長的因素

市場促進因素

腦腫瘤和神經系統疾病發生率不斷上升

神經外科器械市場的主要驅動力是全球腦腫瘤和神經系統疾病發生率的不斷上升，進而促使手術數量的增加，支撐著整個市場的發展。腦部及其他中樞神經系統腫瘤、腦血管疾病、水腦症、癲癇、運動障礙和神經創傷等疾病共同構成了一個龐大且不斷成長的神經外科手術患者群體。根據美國國家腦腫瘤協會統計，美國約有70萬人患有腦瘤，其中腦膜瘤和膠質瘤佔成人惡性腦腫瘤的大多數，佔了腫瘤切除手術的很大一部分。由於診斷技術的進步、影像學檢查對病變的早期和頻繁發現以及人口老化（正值發病高峰期），這一負擔正在不斷加重。此外，每個最終需要手術的病變診斷都需要用到構成該市場的各種器械，包括導航設備、影像設備、電動手術器械、超音波吸引器和硬腦膜修復器械。由於許多神經系統疾病是慢性且進行性的，因此治療需求是持續性的而非暫時性的，將以往僅以藥物治療為主的疾病納入神經外科治療將進一步擴大患者群體。這些疾病的負擔沉重且日益加重，因此，重點在於採用最有價值的神經外科器械進行的手術，從而為市場成長奠定最堅實的基礎。

人口老化以及與老齡化。

人口老化是神經外科器械市場的重要結構性促進因素。這是因為神經外科治療的疾病主要集中在老年族群中，而已開發國家和越來越多的開發中國家的人口老化正在逐年擴大面臨風險的患者群體。腦腫瘤、導致動脈瘤和出血的腦血管疾病、正常水腦症以及需要神經外科干預的脊椎退化性和退化性疾病的發生率均老齡化成長而增加。因此，老年人口數量和比例的持續成長直接轉化為對神經外科手術需求的增加。老年患者尤其受益於微創和影像引導治療，這些治療可以減輕手術帶來的生理負擔。對於老年患者族群而言，長時間麻醉和開顱手術風險的增加進一步凸顯了對先進導航、內視鏡和機器人輔助手術設備的臨床需求，這些設備能夠實現微創治療。正常水腦症一種老年人常見疾病，可透過腦脊髓液分流手術治療；此外，慢性硬腦膜下血腫的發生率不斷上升，這清楚地顯示了老化與醫療設備需求之間的直接關聯。由於這些人口趨勢是漸進的、可預測的且幾乎不可逆轉的，並且疾病集中在需要干預的人群中，因此老化為長期成長提供了極其穩定的基礎。

市場限制因素

儘管疾病負擔日益加重，技術也日新月異，但神經外科器械市場仍面臨許多重大限制因素。其中最主要的限制因素是先進設備的高成本。導航系統、術中影像和機器人平台都需要大量的資金投入，這使得許多醫院，尤其是新興市場和小規模醫療機構，難以證明其採用的合理性。這一成本壁壘限制了現代神經外科關鍵技術的應用。報銷限制進一步加劇了成本壁壘。針對先進神經外科手術和所需醫療設備的保險覆蓋範圍和賠償金額因地區和保險公司而異，即使有充分的臨床證據，醫療機構也可能難以負擔昂貴的新技術。第三個也是根本性的限制因素是訓練有素的神經外科醫生短缺以及先進醫療設備的學習曲線陡峭。市場上提供的先進導航系統、內視鏡系統和機器人系統依賴技術嫻熟的外科醫生和手術室團隊，但此類人員的取得情況因地區而異，掌握新技術也需要時間。缺乏足夠的專業技術既限制了先進醫療設備的安全部署，也限制了能夠達到與其成本相符的治療效果。神經外科手術本身的複雜性和風險也是阻礙因素，因為一旦出錯後果嚴重，自然需要在引入新的醫療設備和技術時格外謹慎。其他限制因素還包括對植入式且昂貴的神經外科設備進行嚴格而漫長的核准流程，這增加了研發成本並延緩了產品上市。此外，世界許多地區神經外科和復健基礎設施的匱乏意味著很大一部分人口甚至無法獲得基本的神經外科治療。另外，設備更新周期過長也減緩了新平台技術的應用。成本、報銷、人才、監管和基礎設施等因素共同作用，使得神經外科領域的成長雖然強勁，但卻受到許多限制。

目錄

第1章：神經外科器械市場：引言

  • 調查範圍
  • 市場區隔
  • 市場概覽

第2章：神經外科器械市場：摘要整理

  • 主要亮點和市場概覽

第3章：神經外科器械市場：關鍵因素分析

  • 市場促進因素
    • 腦腫瘤和神經系統疾病的發生率增加
    • 與老齡化相關的神經外科疾病
    • 向微創和影像引導神經外科手術過渡
    • 手術機器人與立體定位引導技術的進步
  • 市場限制因素
    • 先進資本設備高成本
    • 保險報銷限制
    • 熟練神經外科醫生短缺和學習曲線
  • 市場機遇
    • 顱內機器人技術、人工智慧和雷射消熔
    • 新興市場和神經外科能力的擴展

第4章：人工智慧、地緣政治、貿易與經濟趨勢

第5章：監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章：波特五力分析

第7章：神經外科器械市場：評估

  • 依產品類型
    • 神經外科導航系統
    • 術中影像系統
    • 定位和機器人引導系統
    • 電動神經外科器械
    • 神經科學用內視鏡
    • 超音波吸力系統
    • 動脈瘤和神經血管夾
    • 用於腦脊髓液管理的醫療設備
    • 神經監測和顱內壓測量裝置
    • 用於硬腦膜修復和密封劑塗抹的裝置
    • 顱骨穩定與固定裝置
    • 雷射間質熱療系統
    • 神經外科器械及配件
  • 用途別
    • 腦腫瘤手術
    • 神經血管外科
    • 水腦症和腦脊髓液管理
    • 功能神經外科
    • 神經創傷
    • 脊椎和神經外科
    • 其他
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 專業神經外科和學術機構
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區

第8章：神經外科器材市場：競爭格局

  • 競爭分析
  • 企業市場占有率分析（加值服務）

第9章 神經外科器械市場：新創企業資金籌措與投資趨勢

第10章 神經外科器材市場：公司概況與產品概況

  • Medtronic plc
  • Stryker Corporation
  • Integra LifeSciences Holdings Corporation
  • B. Braun SE（Aesculap）
  • Johnson & Johnson MedTech（DePuy Synthes）
  • Zimmer Biomet Holdings Inc.
  • Brainlab AG
  • KARL STORZ SE & Co. KG
  • Elekta AB
  • Globus Medical Inc.

第11章：KOL的觀點

第12章：專案式教學方法

第13章：關於 DelveInsight

第14章 免責聲明與聯絡方式

Product Code: DIMDCL0987

Neurosurgery Devices Market Summary

Overview:

  • The global neurosurgery devices market was valued at USD 14.50 billion in 2025 and is projected to reach USD 45.32 billion by 2034.
  • The market is expected to expand at a CAGR of 13.5% during the forecast period 2026-2034, supported by the rising prevalence of brain tumors and neurological disorders, the shift toward minimally invasive and image-guided neurosurgery, advances in surgical robotics and stereotactic guidance, and continuous technological innovation across the neurosurgical device portfolio.
  • By product type, the neurosurgical navigation systems segment dominated the neurosurgery devices market with a 22% share in 2025.
  • By application, the brain tumor surgery segment dominated the neurosurgery devices market with a 30% share in 2025.
  • By end-user, the hospitals segment dominated the neurosurgery devices market with a 78% share in 2025.
  • North America accounted for the largest share of the neurosurgery devices market at 38% in 2025, while Asia-Pacific is anticipated to register the fastest growth through 2034.

Neurosurgery devices are the instruments, implants, and capital systems used to diagnose, access, treat, and monitor disorders of the brain, spine, and peripheral nervous system, spanning the tools that plan and guide a neurosurgical procedure, the instruments that perform it, and the implants and materials that repair and manage its consequences. The market is organized by the product supplied, the surgical application, and the setting of care, and the product structure adopted in this report follows the way the leading manufacturers organize their neurosurgery portfolios. Platform technologies include neurosurgical navigation systems that locate anatomy in real time, intraoperative imaging systems, and the stereotactic and robotic guidance systems that position instruments along a planned trajectory. Powered instruments, principally the high-speed surgical drills used to open and shape bone, and neuroendoscopes for endoscopic and skull-base approaches, perform the access and resection. Ultrasonic aspiration systems remove tumor tissue, aneurysm and neurovascular clips occlude vascular lesions, and laser interstitial thermal therapy systems ablate lesions under image guidance. Cerebrospinal fluid management devices, comprising shunts, programmable valves, and external drainage, treat hydrocephalus and manage intracranial pressure; neuromonitoring and intracranial pressure devices track the injured or operated brain; dural repair and sealant devices restore the dura, and cranial stabilization and fixation devices immobilize the head and reconstruct the skull. The contemporary market is defined by the migration toward minimally invasive and image-guided surgery, the rapid advance of cranial robotics, and the integration of artificial intelligence into surgical planning and navigation.

Neurosurgery Devices Market Key Growth Drivers

  • The rising global prevalence of brain tumors and neurological disorders, with the National Brain Tumor Society reporting that some 700,000 people in the United States are living with a brain tumor, sustaining demand for tumor resection and related devices.
  • The aging of the population, which increases the incidence of brain tumors, cerebrovascular disease, normal pressure hydrocephalus, and the degenerative conditions that require neurosurgical intervention.
  • The shift toward minimally invasive and image-guided neurosurgery, in which navigation, endoscopy, and tubular access reduce the length of hospital stay and the risk of complications relative to open craniotomy.
  • The rapid advance of surgical robotics and stereotactic guidance, exemplified by cranial robotic platforms that position instruments for biopsy, electrode placement, and laser ablation with high accuracy.
  • Continuous technological innovation across the portfolio, including intraoperative imaging, laser interstitial thermal therapy, ultrasonic aspiration, and the integration of artificial intelligence and tractography into surgical planning.
  • Rising neurosurgical procedure volumes across tumor resection, hydrocephalus management, epilepsy and functional surgery, and neurotrauma, driven by improving diagnosis and expanding access.
  • Increasing healthcare investment and the expansion of neurosurgical capacity across emerging markets, which convert a historically underserved burden into treated procedures.

Key Companies in Neurosurgery Devices Market

The competitive landscape is led by the following active manufacturers:

  • Medtronic plc
  • Stryker Corporation
  • Integra LifeSciences Holdings Corporation
  • B. Braun SE (Aesculap)
  • Johnson & Johnson MedTech (DePuy Synthes)
  • Zimmer Biomet Holdings Inc.
  • Brainlab AG
  • KARL STORZ SE & Co. KG
  • Elekta AB
  • Globus Medical Inc.

Factors Contributing to the Growth of the Neurosurgery Devices Market

Market Drivers

Rising Prevalence of Brain Tumors and Neurological Disorders

The foundational driver of the neurosurgery devices market is the rising global prevalence of brain tumors and neurological disorders, which generates the procedural volume upon which the entire category depends. Brain and other central nervous system tumors, cerebrovascular disease, hydrocephalus, epilepsy, movement disorders, and neurotrauma together produce a large and growing population requiring neurosurgical intervention, and the National Brain Tumor Society reports that some 700,000 people in the United States are living with a brain tumor, of which the meningiomas and gliomas that dominate adult malignant disease drive a substantial share of tumor resection procedures. The burden is rising as diagnosis improves, as imaging detects lesions earlier and more often, and as the population ages into the decades of peak incidence, and each diagnosed lesion that proceeds to surgery draws upon the navigation, imaging, powered instruments, ultrasonic aspiration, and dural repair devices that constitute the market. The chronic and progressive nature of many neurological conditions means that the need is durable rather than episodic, and the expansion of neurosurgical capability into conditions previously managed medically further enlarges the addressable population. Because the disease burden is large, rising, and concentrated in exactly the procedures that consume the highest-value neurosurgical devices, it provides the most durable foundation for market growth.

Aging Population and Rising Incidence of Age-Related Neurosurgical Disease

Demographic aging is a powerful structural driver of the neurosurgery devices market, because the conditions that neurosurgery treats are concentrated in older adults and because the aging of the population across the developed and increasingly the developing world expands the at-risk pool year on year. The incidence of brain tumors, of the cerebrovascular disease that produces aneurysms and hemorrhage, of normal pressure hydrocephalus, and of the degenerative spinal and functional conditions that require neurosurgical intervention all rise with age, so the steady increase in the number and proportion of older adults translates directly into rising neurosurgical demand. Older patients also benefit particularly from the minimally invasive and image-guided approaches that reduce the physiological burden of surgery, since the risks of prolonged anesthesia and open craniotomy are greater in this group, which strengthens the clinical case for the advanced navigation, endoscopy, and robotic devices that enable less invasive intervention. Normal pressure hydrocephalus, a condition of the elderly treated by cerebrospinal fluid shunting, exemplifies the direct link between aging and device demand, as does the rising incidence of chronic subdural hematoma. Because these demographic trends are slow, predictable, and effectively irreversible, and because they concentrate disease in the population increasingly offered intervention, aging provides an unusually stable foundation for long-term growth.

Market Restraints

Despite a rising disease burden and rapid technological advances, the neurosurgery devices market faces several material constraints. The most significant is the high cost of the advanced capital systems, since navigation, intraoperative imaging, and robotic platforms represent substantial capital investments that many hospitals, and particularly those in emerging markets and smaller centers, find difficult to justify, and this cost barrier restricts the adoption of the very technologies that define modern neurosurgery. Reimbursement constraints compound the cost barrier, since the coverage and payment available for advanced neurosurgical procedures and the devices they require vary across jurisdictions and payers and can make it financially unviable for a center to adopt a new and expensive technology even where the clinical case is strong. A third and fundamental constraint is the shortage of trained neurosurgeons and the steep learning curve associated with advanced devices, since the sophisticated navigation, endoscopic, and robotic systems that the market supplies depend upon skilled surgeons and operating room teams whose availability is uneven and whose training in new technology takes time, and inadequate access to this expertise limits both the safe adoption of advanced devices and the achievement of the outcomes that justify their cost. The complexity and risk of neurosurgical procedures themselves impose a constraint, since the consequences of error are severe and the adoption of a new device or technique is appropriately cautious. Additional constraints include the stringent and lengthy regulatory pathways governing implantable and capital neurosurgical devices, which raise development cost and delay market entry; the limited neurosurgical and rehabilitation infrastructure across much of the world, which leaves a large share of the population unable to access even basic neurosurgical care; and the long capital replacement cycles that slow the diffusion of new platform technology. Together these cost, reimbursement, workforce, regulatory, and infrastructure factors ensure that growth, while robust, proceeds against genuine constraint.

Neurosurgery Devices Market Segment Analysis

The global neurosurgery devices market by product type (neurosurgical navigation systems, intraoperative imaging systems, stereotactic and robotic guidance systems, neurosurgical powered instruments, neuroendoscopes, ultrasonic aspiration systems, aneurysm and neurovascular clips, cerebrospinal fluid management devices, neuromonitoring and intracranial pressure devices, dural repair and sealant devices, cranial stabilization and fixation devices, laser interstitial thermal therapy systems, and neurosurgical hand instruments and accessories), by application (brain tumor surgery, cerebrovascular surgery, hydrocephalus and cerebrospinal fluid management, functional neurosurgery, neurotrauma, spinal neurosurgery, and others), by end-user (hospitals, ambulatory surgical centers, and specialty neurosurgery and academic centers), and by geography (North America, Europe, Asia-Pacific, and the Rest of the World).

By Product Type

Dominant Subsegment: Neurosurgical Navigation Systems.

The neurosurgical navigation systems segment accounted for a 22% share of the neurosurgery devices market in 2025. Neurosurgical navigation systems dominate the product-type structure because image-guided surgery has become the anchor of the modern neurosurgical suite and because the navigation platform is the high-value system upon which the powered instruments, imaging, and robotics of a procedure are organized. A navigation system precisely locates anatomical structures in open and minimally invasive cranial and spinal procedures, allowing the surgeon to relate the operative field to preoperative and intraoperative imaging and to protect eloquent brain and vascular structures during resection, and it has become the standard of care for a widening range of cranial procedures. The leading manufacturers position navigation as the platform of their neurosurgery portfolios, integrating it with powered drills, imaging, and robotic guidance into unified surgical ecosystems, and the capital value, the associated disposables, and the service revenue together make navigation the largest single product category. Cerebrospinal fluid management devices constitute a substantial category by volume, encompassing the shunts, programmable valves, and external drainage used in the very common treatment of hydrocephalus, and neurosurgical powered instruments, principally the high-speed surgical drills used in essentially every cranial and spinal procedure, form another large category. Stereotactic and robotic guidance systems are the fastest-growing category, while ultrasonic aspiration, aneurysm clips, neuroendoscopes, laser ablation, dural repair, neuromonitoring, cranial stabilization, and hand instruments complete the structure. Neurosurgical navigation systems are expected to retain their leading share throughout the forecast period.

By Application

Dominant Subsegment: Brain Tumor Surgery.

The brain tumor surgery segment accounted for a 30% share of the neurosurgery devices market in 2025. Brain tumor surgery dominates the application structure because tumor resection is the highest-value neurosurgical procedure by device intensity, drawing upon the widest range of advanced devices in the portfolio, and because the large and rising population of brain tumor patients sustains a substantial and growing procedure volume. The resection of a brain tumor engages navigation to localize the lesion and protect function, intraoperative imaging to confirm the extent of resection, powered instruments to open the skull, ultrasonic aspiration to remove the tumor while sparing adjacent tissue, dural repair and sealants to close, and increasingly laser interstitial thermal therapy to ablate deep or inoperable lesions and robotic guidance to place biopsy needles and ablation catheters, so a single tumor case consumes more high-value device content than almost any other neurosurgical procedure. The National Brain Tumor Society reports that some 700,000 people in the United States are living with a brain tumor, and the meningiomas and gliomas that dominate adult disease drive a large and durable resection volume. Cerebrovascular surgery, encompassing the clipping of aneurysms and the treatment of vascular malformations, constitutes a substantial second application, and hydrocephalus and cerebrospinal fluid management, functional neurosurgery for epilepsy and movement disorders, neurotrauma, and spinal neurosurgery complete the structure. Brain tumor surgery is expected to retain its leading share throughout the forecast period.

Neurosurgery Devices Market Region Analysis

Dominant Region: North America

North America accounted for a 38% share of the global neurosurgery devices market in 2025. The region is expected to account for the largest share of the global market, supported by advanced healthcare infrastructure, high healthcare expenditure, extensive research and development activity, and the presence and headquarters of many of the leading neurosurgery device manufacturers. The United States hosts the largest concentration of neurosurgical capacity in the world, with a high density of academic medical centers and specialized neuroscience institutes that perform the highest procedure volumes and are the earliest adopters of advanced navigation, imaging, and robotic systems, and the strong reimbursement environment for complex neurosurgical procedures supports the adoption of premium technology. The concentration of manufacturer research and development and commercial operations in the region, exemplified by the leading navigation, robotics, and implant portfolios headquartered or principally operated in North America, ensures early access to innovation and deep clinical and technical support, and the region leads in the regulatory clearance and early commercialization of new neurosurgical technologies. The rising prevalence of brain tumors and neurological disease, the aging population, and the high adoption of minimally invasive and image-guided surgery reinforce the position of the region. The region is expected to retain its leading position throughout the forecast period.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is projected to register the fastest compound annual growth rate in the neurosurgery devices market through 2034. The region is emerging as the principal growth engine of the market, propelled by very large populations, a rising burden of brain tumors, cerebrovascular disease, trauma, and hydrocephalus, expanding healthcare infrastructure, and increasing investment in neurosurgical capacity across China, Japan, India, and South Korea. The region combines the largest populations in the world with a historically underserved neurosurgical burden, and the expansion of neurosurgical capacity, including the building and equipping of neurosurgical centers, the training of neurosurgeons, and the acquisition of navigation, imaging, endoscopy, and robotic systems, is converting a large unmet need into demand. Governments and private providers are investing heavily in advanced healthcare infrastructure, and the rising incidence of the conditions that neurosurgery treats, driven by aging and by the epidemiological transition, creates rapidly growing demand. China combines a very large population with a rapidly developing domestic medical device industry and growing neurosurgical capacity, Japan combines an aged population with sophisticated neurosurgical and robotics capability, and India combines a very large population with a rapidly expanding private neurosurgical sector. The coexistence of demand for premium and cost-effective devices creates opportunity for international and regional manufacturers alike. Regional growth is expected to exceed the global average across every segment.

Regional Commentary

North America

North America leads on value and innovation, holding a 38% share in 2025. The region combines advanced healthcare infrastructure, high expenditure, and strong reimbursement for complex neurosurgery with a high density of academic and specialized neuroscience centers and the headquarters and principal operations of many leading manufacturers. High adoption of minimally invasive and image-guided surgery, early access to robotic and navigation innovation, and the rising burden of brain tumors and neurological disease reinforce the position of the region. Near-term dynamics are shaped by the advance of cranial robotics, the integration of artificial intelligence and tractography into navigation, laser interstitial thermal therapy, and the extension of unified planning, navigation, and robotics platforms into cranial procedures.

Europe

Europe is a large and sophisticated market, home to several of the leading neurosurgery device manufacturers, including major navigation, robotics, endoscopy, aneurysm clip, and cerebrospinal fluid device companies, and supported by well-developed healthcare systems, strong academic neurosurgery, and established clinical pathways, with Germany, France, and the United Kingdom the principal markets. The region hosts distinctive manufacturer strengths, including the German and European leadership in aneurysm clips, neuroendoscopy, and programmable cerebrospinal fluid valves, and it combines a substantial and aging patient population with generally supportive public healthcare and high adoption of advanced devices. Reimbursement varies by country, and public budget constraints temper the pace of capital adoption, but the region sustains a competitive market served by both global and specialized regional participants.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by very large populations, a rising burden of brain tumors, cerebrovascular disease, trauma, and hydrocephalus, expanding healthcare infrastructure, and increasing investment in neurosurgical capacity across China, Japan, India, and South Korea. The expansion of neurosurgical centers, the training of surgeons, and the acquisition of navigation, imaging, endoscopy, and robotic systems are converting a historically underserved burden into demand. China combines a very large population with a developing domestic device industry, Japan combines an aged population with advanced robotics capability, and India combines a very large population with a rapidly expanding private sector. Growth exceeds the global average across every segment.

Rest of World

The Rest of the World comprises the Middle East, Africa, and South America. Access is highly stratified. The Gulf states have invested substantially in advanced neurosurgical and neuroscience capacity, and the larger Latin American markets, particularly Brazil, support established neurosurgical programs and growing device adoption, together representing steady growth. Much of Africa faces severe constraints in neurosurgical infrastructure and in the trained neurosurgeons required, so a large share of the neurosurgical burden is never treated, and the World Health Organization has emphasized the substantial global gap between the need for neurosurgical care and its availability. Regional growth will be driven by investment in neurosurgical infrastructure, the training of surgeons, the rising burden of trauma, tumors, and cerebrovascular disease, and the availability of cost-appropriate devices from regional and international manufacturers.

Neurosurgery Devices Market Competitive Landscape

The global neurosurgery devices market is classified as Moderately Concentrated. The market is led by a small group of large medical technology companies with broad neurosurgery portfolios spanning navigation, imaging, robotics, powered instruments, and implants, which hold a substantial combined share, complemented by specialized manufacturers of neuroendoscopes, aneurysm clips, laser ablation systems, cerebrospinal fluid devices, and cranial robotics. Competition centers upon the breadth and integration of the neurosurgery portfolio, the sophistication of navigation and robotics, the depth of the implant and disposables franchise, clinical evidence and surgeon training, and increasingly upon artificial intelligence and unified surgical ecosystems. The competitive landscape is evaluated across the following dimensions:

  • Market concentration: Moderately concentrated, with a small group of large diversified manufacturers holding a substantial combined share across the platform and implant categories alongside specialized companies in endoscopy, aneurysm clips, laser ablation, cerebrospinal fluid devices, and robotics, and with the scale, portfolio breadth, and capital and clinical support of the leaders constituting a barrier to entry.
  • Leading players: Medtronic leads with the broadest neurosurgery portfolio spanning navigation, imaging, robotics, powered instruments, cerebrospinal fluid management, and laser ablation, with Stryker and Integra LifeSciences strong across navigation, powered instruments, ultrasonic aspiration, dural repair, cerebrospinal fluid, and cranial stabilization, B. Braun through Aesculap in aneurysm clips, endoscopy, instruments, and shunts, and Johnson & Johnson MedTech, Zimmer Biomet, Brainlab, KARL STORZ, Elekta, and Globus Medical strong in defined platform and robotic segments.
  • Geographic reach: The leading participants maintain global commercial, clinical, and service organizations, which are decisive because navigation, imaging, and robotic systems require local installation, training, and service, while specialized European manufacturers lead in aneurysm clips, endoscopy, and cerebrospinal fluid valves, and regional manufacturers serve domestic and cost-sensitive markets, particularly across Asia-Pacific.
  • Product portfolio strength: Competitive advantage rests upon offering an integrated neurosurgery ecosystem spanning planning, navigation, imaging, powered instruments, robotics, and the implants and disposables consumed in each procedure, since surgeons and hospitals value a unified and supported workflow from a single accountable supplier, though specialized manufacturers compete effectively through a single superior device such as an aneurysm clip, endoscope, or laser ablation system.
  • Pipeline strength: Development is concentrated in cranial robotics and stereotactic guidance, artificial-intelligence-enabled planning and navigation including tractography, unified planning, navigation, and robotics platforms, laser interstitial thermal therapy, next-generation intraoperative imaging, and the integration of brain-computer interface and mapping technologies with surgical navigation.
  • Strategic partnerships: Collaboration spans the integration of surgical navigation with imaging and robotic systems, partnerships with imaging companies for intraoperative imaging, and alliances with emerging technology developers, exemplified by the partnership to integrate a cortical brain-computer interface with a surgical navigation platform, extending the reach of the neurosurgical ecosystem.
  • M&A activity: Acquisition is a defining dynamic through which the diversified leaders assemble integrated neurosurgery portfolios and acquire specialized technologies, exemplified by the consolidation of a major specialty surgical franchise combining dural repair, cerebrospinal fluid, neurocritical care, ultrasonic surgery, and cranial stabilization, and by the continued acquisition of robotics, laser ablation, and navigation capability.
  • Innovation focus: Innovation is shifting toward cranial robotics, artificial intelligence and tractography in planning and navigation, unified surgical ecosystems connecting planning, navigation, imaging, and robotics, minimally invasive and endoscopic approaches, laser interstitial thermal therapy, and the integration of mapping and brain-computer interface technologies with neurosurgical platforms.
  • Regulatory standing: Regulatory clearance and approval for implantable and capital neurosurgical devices in the major jurisdictions is a decisive credential, and the stringent and lengthy pathways governing these devices both raise the barrier to entry and reward the scale and regulatory capability of the leading manufacturers, while the safety-critical nature of neurosurgical devices makes demonstrated clinical evidence essential to adoption.

Neurosurgery Devices Market Recent Developmental Activities

In March 2026, Medtronic expanded the United States Food and Drug Administration clearance of its Stealth AXiS surgical system from spine into cranial and ENT procedures, unifying planning, navigation, and robotics on one platform and adding artificial-intelligence-based tractography and integrated intraoperative imaging. Strategic significance: extending a unified planning, navigation, and robotics platform into cranial procedures advanced the convergence toward integrated surgical ecosystems and brought artificial-intelligence-based tractography, which maps the white-matter tracts a surgeon must avoid, into the cranial navigation workflow of the market leader.

Neurosurgery Devices Market Segmentation

Neurosurgery Devices Market Assessment by Product Type

  • Neurosurgical Navigation Systems
  • Intraoperative Imaging Systems
  • Stereotactic and Robotic Guidance Systems
  • Neurosurgical Powered Instruments
  • Neuroendoscopes
  • Ultrasonic Aspiration Systems
  • Aneurysm and Neurovascular Clips
  • Cerebrospinal Fluid Management Devices
  • Neuromonitoring and Intracranial Pressure Devices
  • Dural Repair and Sealant Devices
  • Cranial Stabilization and Fixation Devices
  • Laser Interstitial Thermal Therapy Systems
  • Neurosurgical Hand Instruments and Accessories

Neurosurgery Devices Market Assessment by Application

  • Brain Tumor Surgery
  • Cerebrovascular Surgery
  • Hydrocephalus and Cerebrospinal Fluid Management
  • Functional Neurosurgery
  • Neurotrauma
  • Spinal Neurosurgery
  • Others

Neurosurgery Devices Market Assessment by End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Neurosurgery and Academic Centers

Neurosurgery Devices Market Assessment by Geography

  • North America
  • United States Neurosurgery Devices Market Size in USD million (2023-2034)
  • Canada Neurosurgery Devices Market Size in USD million (2023-2034)
  • Mexico Neurosurgery Devices Market Size in USD million (2023-2034)
  • Europe
  • France Neurosurgery Devices Market Size in USD million (2023-2034)
  • Germany Neurosurgery Devices Market Size in USD million (2023-2034)
  • United Kingdom Neurosurgery Devices Market Size in USD million (2023-2034)
  • Italy Neurosurgery Devices Market Size in USD million (2023-2034)
  • Spain Neurosurgery Devices Market Size in USD million (2023-2034)
  • Rest of Europe Neurosurgery Devices Market Size in USD million (2023-2034)
  • Asia-Pacific
  • China Neurosurgery Devices Market Size in USD million (2023-2034)
  • Japan Neurosurgery Devices Market Size in USD million (2023-2034)
  • India Neurosurgery Devices Market Size in USD million (2023-2034)
  • Australia Neurosurgery Devices Market Size in USD million (2023-2034)
  • South Korea Neurosurgery Devices Market Size in USD million (2023-2034)
  • Rest of Asia-Pacific Neurosurgery Devices Market Size in USD million (2023-2034)
  • Rest of the World
  • Middle East Neurosurgery Devices Market Size in USD million (2023-2034)
  • Africa Neurosurgery Devices Market Size in USD million (2023-2034)
  • South America Neurosurgery Devices Market Size in USD million (2023-2034)

Frequently Asked Questions:

Q1. At what rate is the neurosurgery devices market expected to grow?

The global neurosurgery devices market is projected to grow at a compound annual growth rate of 13.5% during the forecast period from 2026 to 2034.

Q2. What is the current and projected size of the neurosurgery devices market?

On a DelveInsight-modeled basis, the global neurosurgery devices market was valued at USD 14.50 billion in 2025 and is projected to reach USD 45.32 billion by 2034.

Q3. Which region dominates the neurosurgery devices market?

North America dominated the neurosurgery devices market with a 38% share in 2025 on a modeled basis, supported by advanced healthcare infrastructure, high healthcare expenditure, strong reimbursement for complex neurosurgery, a high density of academic and specialized neuroscience centers, and the presence and headquarters of many of the leading manufacturers. Asia-Pacific is projected to record the fastest compound annual growth rate through 2034, driven by very large populations, a rising burden of brain tumors, cerebrovascular disease, trauma, and hydrocephalus, and expanding neurosurgical capacity across China, Japan, India, and South Korea.

Q4. What are the key factors driving growth in the neurosurgery devices market?

The principal drivers are the rising prevalence of brain tumors and neurological disorders, with the National Brain Tumor Society reporting some 700,000 people living with a brain tumor in the United States; the aging of the population, which increases the incidence of tumors, cerebrovascular disease, and hydrocephalus; the shift toward minimally invasive and image-guided neurosurgery; the rapid advance of surgical robotics and stereotactic guidance; continuous technological innovation including laser ablation, intraoperative imaging, and artificial intelligence in planning and navigation; rising neurosurgical procedure volumes; and expanding access and investment in emerging markets.

Q5. Who are the major players in the neurosurgery devices market?

The market is moderately concentrated and led by Medtronic plc, which holds the broadest neurosurgery portfolio, alongside Stryker Corporation and Integra LifeSciences Holdings Corporation, which are strong across navigation, powered instruments, ultrasonic aspiration, dural repair, cerebrospinal fluid, and cranial stabilization, and B. Braun SE through Aesculap in aneurysm clips, endoscopy, and shunts. Additional leaders include Johnson & Johnson MedTech (DePuy Synthes), Zimmer Biomet Holdings Inc., Brainlab AG, KARL STORZ SE & Co. KG, Elekta AB, and Globus Medical Inc., alongside Monteris Medical, Renishaw plc, NICO Corporation, Peter Lazic GmbH, and Sophysa Ltd.

Table of Contents

1. Neurosurgery Devices Market Introduction

  • 1.1. Scope of the Report
  • 1.2. Market Segmentation
  • 1.3. Market Overview at a Glance

2. Neurosurgery Devices Market Executive Summary

  • 2.1. Key Highlights and Market Snapshot

3. Neurosurgery Devices Market Key Factors Analysis

  • 3.1. Market Drivers
    • 3.1.1. Rising Prevalence of Brain Tumors and Neurological Disorders
    • 3.1.2. Aging Population and Age-Related Neurosurgical Disease
    • 3.1.3. Shift Toward Minimally Invasive and Image-Guided Neurosurgery
    • 3.1.4. Advances in Surgical Robotics and Stereotactic Guidance
  • 3.2. Market Restraints
    • 3.2.1. High Cost of Advanced Capital Systems
    • 3.2.2. Reimbursement Constraints
    • 3.2.3. Shortage of Trained Neurosurgeons and Learning Curve
  • 3.3. Market Opportunities
    • 3.3.1. Cranial Robotics, Artificial Intelligence, and Laser Ablation
    • 3.3.2. Emerging Markets and Expanding Neurosurgical Capacity

4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments

5. Regulatory Analysis

  • 5.1. The United States
  • 5.2. Europe
  • 5.3. Japan
  • 5.4. China

6. Neurosurgery Devices Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Neurosurgery Devices Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Neurosurgical Navigation Systems
    • 7.1.2. Intraoperative Imaging Systems
    • 7.1.3. Stereotactic and Robotic Guidance Systems
    • 7.1.4. Neurosurgical Powered Instruments
    • 7.1.5. Neuroendoscopes
    • 7.1.6. Ultrasonic Aspiration Systems
    • 7.1.7. Aneurysm and Neurovascular Clips
    • 7.1.8. Cerebrospinal Fluid Management Devices
    • 7.1.9. Neuromonitoring and Intracranial Pressure Devices
    • 7.1.10. Dural Repair and Sealant Devices
    • 7.1.11. Cranial Stabilization and Fixation Devices
    • 7.1.12. Laser Interstitial Thermal Therapy Systems
    • 7.1.13. Neurosurgical Hand Instruments and Accessories
  • 7.2. By Application
    • 7.2.1. Brain Tumor Surgery
    • 7.2.2. Cerebrovascular Surgery
    • 7.2.3. Hydrocephalus and Cerebrospinal Fluid Management
    • 7.2.4. Functional Neurosurgery
    • 7.2.5. Neurotrauma
    • 7.2.6. Spinal Neurosurgery
    • 7.2.7. Others
  • 7.3. By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Specialty Neurosurgery and Academic Centers
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Neurosurgery Devices Market Size in USD million (2023-2034)
      • 7.4.1.2. Canada Neurosurgery Devices Market Size in USD million (2023-2034)
      • 7.4.1.3. Mexico Neurosurgery Devices Market Size in USD million (2023-2034)
    • 7.4.2. Europe
      • 7.4.2.1. France Neurosurgery Devices Market Size in USD million (2023-2034)
      • 7.4.2.2. Germany Neurosurgery Devices Market Size in USD million (2023-2034)
      • 7.4.2.3. United Kingdom Neurosurgery Devices Market Size in USD million (2023-2034)
      • 7.4.2.4. Italy Neurosurgery Devices Market Size in USD million (2023-2034)
      • 7.4.2.5. Spain Neurosurgery Devices Market Size in USD million (2023-2034)
      • 7.4.2.6. Rest of Europe Neurosurgery Devices Market Size in USD million (2023-2034)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Neurosurgery Devices Market Size in USD million (2023-2034)
      • 7.4.3.2. Japan Neurosurgery Devices Market Size in USD million (2023-2034)
      • 7.4.3.3. India Neurosurgery Devices Market Size in USD million (2023-2034)
      • 7.4.3.4. Australia Neurosurgery Devices Market Size in USD million (2023-2034)
      • 7.4.3.5. South Korea Neurosurgery Devices Market Size in USD million (2023-2034)
      • 7.4.3.6. Rest of Asia-Pacific Neurosurgery Devices Market Size in USD million (2023-2034)
    • 7.4.4. Rest of the World
      • 7.4.4.1. Middle East Neurosurgery Devices Market Size in USD million (2023-2034)
      • 7.4.4.2. Africa Neurosurgery Devices Market Size in USD million (2023-2034)
      • 7.4.4.3. South America Neurosurgery Devices Market Size in USD million (2023-2034)

8. Neurosurgery Devices Market Competitive Landscape

  • 8.1. Competitive Analysis
  • 8.2. Company Share Analysis (Premium Offering)

9. Neurosurgery Devices Market Startup Funding and Investment Trends

10. Neurosurgery Devices Market Company and Product Profiles

  • 10.1. Medtronic plc
    • 10.1.1. Company Overview
    • 10.1.2. Company Snapshot
    • 10.1.3. Financial Overview
    • 10.1.4. Product Listing
    • 10.1.5. Strategic Initiatives / Entropy
  • 10.2. Stryker Corporation
    • 10.2.1. Company Overview
    • 10.2.2. Company Snapshot
    • 10.2.3. Financial Overview
    • 10.2.4. Product Listing
    • 10.2.5. Strategic Initiatives / Entropy
  • 10.3. Integra LifeSciences Holdings Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Company Snapshot
    • 10.3.3. Financial Overview
    • 10.3.4. Product Listing
    • 10.3.5. Strategic Initiatives / Entropy
  • 10.4. B. Braun SE (Aesculap)
    • 10.4.1. Company Overview
    • 10.4.2. Company Snapshot
    • 10.4.3. Financial Overview
    • 10.4.4. Product Listing
    • 10.4.5. Strategic Initiatives / Entropy
  • 10.5. Johnson & Johnson MedTech (DePuy Synthes)
    • 10.5.1. Company Overview
    • 10.5.2. Company Snapshot
    • 10.5.3. Financial Overview
    • 10.5.4. Product Listing
    • 10.5.5. Strategic Initiatives / Entropy
  • 10.6. Zimmer Biomet Holdings Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Company Snapshot
    • 10.6.3. Financial Overview
    • 10.6.4. Product Listing
    • 10.6.5. Strategic Initiatives / Entropy
  • 10.7. Brainlab AG
    • 10.7.1. Company Overview
    • 10.7.2. Company Snapshot
    • 10.7.3. Financial Overview
    • 10.7.4. Product Listing
    • 10.7.5. Strategic Initiatives / Entropy
  • 10.8. KARL STORZ SE & Co. KG
    • 10.8.1. Company Overview
    • 10.8.2. Company Snapshot
    • 10.8.3. Financial Overview
    • 10.8.4. Product Listing
    • 10.8.5. Strategic Initiatives / Entropy
  • 10.9. Elekta AB
    • 10.9.1. Company Overview
    • 10.9.2. Company Snapshot
    • 10.9.3. Financial Overview
    • 10.9.4. Product Listing
    • 10.9.5. Strategic Initiatives / Entropy
  • 10.10. Globus Medical Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Company Snapshot
    • 10.10.3. Financial Overview
    • 10.10.4. Product Listing
    • 10.10.5. Strategic Initiatives / Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer and Contact Us

List of Tables

  • Table 1: Global Neurosurgery Devices Market Size in USD million (2023-2034)
  • Table 2: Global Neurosurgery Devices Market Size by Product Type in USD million (2023-2034)
  • Table 3: Global Neurosurgery Devices Market Size by Application in USD million (2023-2034)
  • Table 4: Global Neurosurgery Devices Market Size by End-User in USD million (2023-2034)
  • Table 5: Neurosurgery Devices Market Size in North America in USD million (2023-2034)
  • Table 6: Neurosurgery Devices Market Size in the United States in USD million (2023-2034)
  • Table 7: Neurosurgery Devices Market Size in Canada in USD million (2023-2034)
  • Table 8: Neurosurgery Devices Market Size in Mexico in USD million (2023-2034)
  • Table 9: Neurosurgery Devices Market Size in Europe in USD million (2023-2034)
  • Table 10: Neurosurgery Devices Market Size in France in USD million (2023-2034)
  • Table 11: Neurosurgery Devices Market Size in Germany in USD million (2023-2034)
  • Table 12: Neurosurgery Devices Market Size in the United Kingdom in USD million (2023-2034)
  • Table 13: Neurosurgery Devices Market Size in Italy in USD million (2023-2034)
  • Table 14: Neurosurgery Devices Market Size in Spain in USD million (2023-2034)
  • Table 15: Neurosurgery Devices Market Size in the Rest of Europe in USD million (2023-2034)
  • Table 16: Neurosurgery Devices Market Size in Asia-Pacific in USD million (2023-2034)
  • Table 17: Neurosurgery Devices Market Size in China in USD million (2023-2034)
  • Table 18: Neurosurgery Devices Market Size in Japan in USD million (2023-2034)
  • Table 19: Neurosurgery Devices Market Size in India in USD million (2023-2034)
  • Table 20: Neurosurgery Devices Market Size in Australia in USD million (2023-2034)
  • Table 21: Neurosurgery Devices Market Size in South Korea in USD million (2023-2034)
  • Table 22: Neurosurgery Devices Market Size in the Rest of Asia-Pacific in USD million (2023-2034)
  • Table 23: Neurosurgery Devices Market Size in the Rest of the World in USD million (2023-2034)
  • Table 24: Neurosurgery Devices Market Size in the Middle East in USD million (2023-2034)
  • Table 25: Neurosurgery Devices Market Size in Africa in USD million (2023-2034)
  • Table 26: Neurosurgery Devices Market Size in South America in USD million (2023-2034)
  • Table 27: Neurosurgery Devices Market Competitive Landscape
  • Table 28: Neurosurgery Devices Market Startup Funding and Investment Trends

List of Figures

  • Figure 1: Neurosurgery Devices Market Drivers
  • Figure 2: Neurosurgery Devices Market Restraints
  • Figure 3: Neurosurgery Devices Market Opportunities
  • Figure 4: Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
  • Figure 5: Regulatory Analysis of the Neurosurgery Devices Market (the United States)
  • Figure 6: Regulatory Analysis of the Neurosurgery Devices Market (Europe)
  • Figure 7: Regulatory Analysis of the Neurosurgery Devices Market (Japan)
  • Figure 8: Regulatory Analysis of the Neurosurgery Devices Market (China)
  • Figure 9: Porter's Five Forces Analysis of the Neurosurgery Devices Market
  • Figure 10: Competitive Analysis of the Neurosurgery Devices Market
  • Figure 11: Global Neurosurgery Devices Market Size in USD million (2023-2034)
  • Figure 12: Global Neurosurgery Devices Market Size by Product Type in USD million (2023-2034)
  • Figure 13: Global Neurosurgery Devices Market Size by Application in USD million (2023-2034)
  • Figure 14: Global Neurosurgery Devices Market Size by End-User in USD million (2023-2034)
  • Figure 15: Neurosurgery Devices Market Size in North America in USD million (2023-2034)
  • Figure 16: Neurosurgery Devices Market Size in the United States in USD million (2023-2034)
  • Figure 17: Neurosurgery Devices Market Size in Canada in USD million (2023-2034)
  • Figure 18: Neurosurgery Devices Market Size in Mexico in USD million (2023-2034)
  • Figure 19: Neurosurgery Devices Market Size in Europe in USD million (2023-2034)
  • Figure 20: Neurosurgery Devices Market Size in France in USD million (2023-2034)
  • Figure 21: Neurosurgery Devices Market Size in Germany in USD million (2023-2034)
  • Figure 22: Neurosurgery Devices Market Size in the United Kingdom in USD million (2023-2034)
  • Figure 23: Neurosurgery Devices Market Size in Italy in USD million (2023-2034)
  • Figure 24: Neurosurgery Devices Market Size in Spain in USD million (2023-2034)
  • Figure 25: Neurosurgery Devices Market Size in the Rest of Europe in USD million (2023-2034)
  • Figure 26: Neurosurgery Devices Market Size in Asia-Pacific in USD million (2023-2034)
  • Figure 27: Neurosurgery Devices Market Size in China in USD million (2023-2034)
  • Figure 28: Neurosurgery Devices Market Size in Japan in USD million (2023-2034)
  • Figure 29: Neurosurgery Devices Market Size in India in USD million (2023-2034)
  • Figure 30: Neurosurgery Devices Market Size in Australia in USD million (2023-2034)
  • Figure 31: Neurosurgery Devices Market Size in South Korea in USD million (2023-2034)
  • Figure 32: Neurosurgery Devices Market Size in the Rest of Asia-Pacific in USD million (2023-2034)
  • Figure 33: Neurosurgery Devices Market Size in the Rest of the World in USD million (2023-2034)
  • Figure 34: Neurosurgery Devices Market Size in the Middle East in USD million (2023-2034)
  • Figure 35: Neurosurgery Devices Market Size in Africa in USD million (2023-2034)
  • Figure 36: Neurosurgery Devices Market Size in South America in USD million (2023-2034)
  • Figure 37: Neurosurgery Devices Market Competitive Landscape
  • Figure 38: Neurosurgery Devices Market Startup Funding and Investment Trends